Epidemiological, procedure and market data are presented for four market geographies, including the United States, Major Europe (the five largest Western European States), Major Asia-Pacific (encompassing China, India and Japan), and Rest of the World nations. The report projections are based on detailed, clinical and econometric models for the years 2013 through 2019 that are intended to act as a working tool for clients of the report. They provide dynamic models of the covered technologies' utilization patterns and revenue growth within the context of neurointerventional radiology practices in the targeted regions, historic analogies of adoption of similar transcatheter tools and techniques, priorities in local healthcare policies, and the availability of funding, among other factors.
EXECUTIVE SUMMARY 1. Epidemiology and Patients 1.1 Hemorrhagic Stroke 1.1.1 Intracerebral Hemorrhage (ICH) 220.127.116.11 Causes, Risk Factors and Symptoms 18.104.22.168 Incidence and Patients by Major Geography 22.214.171.124 Treatment of Acute ICH 1.1.2 Subarachnoid Hemorrhage (SAH) 126.96.36.199 Causes, Risk Factors and Symptoms 188.8.131.52 Incidence and Patients by Major Geography 184.108.40.206 Treatment of Acute SAH 1.1.3 Cerebral Aneurysms, Arteriovenous Malformations and Hemorrhagic Stroke 1.2 Ischemic Stroke 1.2.1 Thrombotic Stroke - Causes & Mechanisms 1.2.2 Embolic Stroke - Causes & Mechanisms 1.2.3 Hypoperfusion Stroke - Causes & Mechanisms 1.2.4 Symptoms and Risk Factors for Ischemic Stroke 1.2.5 Incidence and Patients by Major Geography 1.2.6 Treatment of Acute Ischemic Stroke 2. Interventional Tools and Techniques for Acute Stroke Management 2.1 Prophylaxis of Hemorrhagic Stroke 2.1.1 Treatment of Cerebral Aneurysms and AVMs 220.127.116.11 Embolization Technologies 18.104.22.168.1 Microcoil Systems 22.214.171.124.2 Liquid Embolic Systems 126.96.36.199.3 Embolization Enabling Stenting Systems 188.8.131.52.4 Cerebral Embolization Procedure Volumes 2.2 Prophylaxis and Treatment of Acute Ischemic Stroke 2.2.1 Carotid Artery Stenting (CAS) 184.108.40.206 Stenting versus Endarterectomy 220.127.116.11 CAS Systems 18.104.22.168 Embolic Protection Devices 22.214.171.124 CAS Procedure Volumes 2.2.2 Left Atrial Appendage (LAA) Closure 126.96.36.199 LAA Closure Technologies 188.8.131.52 LAA Closure Procedure Volumes 2.2.3 Cerebral Thrombectomy 184.108.40.206 Cerebral Thrombectomy Devices 220.127.116.11 Cerebral Thrombectomy Procedure Volumes 2.2.4 Intracranial Stenting 18.104.22.168 Intracranial Stenting Technologies 22.214.171.124 Intracranial Stenting Procedure Volumes 3. Global Markets for Interventional Acute Stroke Therapies 3.1 Cerebral Aneurysm and AVM Embolization Systems 3.1.1 Market Forecast by Major Geography 3.1.2 Competitive Analysis 3.2 Carotid Stenting Systems and Embolic Protection Devices 3.2.1 Market Forecast by Major Geography 3.2.2 Competitive Analysis 3.3 Left Atrial Appendage Closure Systems 3.3.1 Market Forecast by Major Geography 3.3.2 Competitive Analysis 3.4 Cerebral Thrombectomy Systems 3.4.1 Market Forecast by Major Geography 3.4.2 Competitive Analysis 3.5 Intracranial Stenting Systems 3.5.1 Market Forecast by Major Geography 3.5.2 Competitive Analysis 4. Company Profiles 4.1 Aachen Resonance 4.2 Abbott Vascular (Abbott Laboratories) 4.3 Acandis 4.4 Atricure 4.5 Bard Peripheral Vascular (C.R. Bard) 4.6 Boston Scientific 4.7 Codman/DePuy Synthes (Johnson & Johnson) 4.8 Medtronic/Covidien 4.9 MicroVention (Terumo) 4.10 Neuravi 4.11 Penumbra 4.12 Phenox 4.13 St. Jude Medical 4.14 Stryker 5. Major Country/Regional Profiles 5.1 United States 5.2 Major Europe 5.2.1 France 5.2.2 Germany 5.2.3 Italy 5.2.4 Spain 5.2.5 United Kingdom 5.3 Major Asia-Pacific 5.3.1 China 5.3.2 India 5.3.3 Japan